Supernus Wins Ban On Generic Seizure Treatment – Law360

Supernus Wins Ban On Generic Seizure Treatment – Law360


By Adam Lidgett (January 31, 2024, 7:11 pm EST) – A federal judge in New Jersey handed victory to Supernus Pharmaceuticals Inc. in its attempt to block a competitor from marketing a generic version of an anti-seizure drug. called Trokendi XR for the moment….

Law360 is present, and so are you.

A subscription to Law360 puts you at the center of rapidly evolving legal issues, trends and developments so you can act quickly and confidently. More than 200 articles are published daily on more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features like

  • daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • Over 450,000 searchable archived articles

And more!

Experience Law360 today with a 7-day free trial.


Leave a Comment


No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *